The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Paronychia


High impact information on Paronychia


Chemical compound and disease context of Paronychia


Anatomical context of Paronychia


  1. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Segaert, S., Van Cutsem, E. Ann. Oncol. (2005) [Pubmed]
  2. Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited. Sass, J.O., Jakob-Sölder, B., Heitger, A., Tzimas, G., Sarcletti, M. Dermatology (Basel) (2000) [Pubmed]
  3. Allergic contact dermatitis due to thymol in Listerine for treatment of paronychia. Fisher, A.A. Cutis; cutaneous medicine for the practitioner. (1989) [Pubmed]
  4. Nutritional, immunologic and psychological responses to a 7250 km run. Mertens, D.J., Rhind, S., Berkhoff, F., Dugmore, D., Shek, P.N., Shephard, R.J. The Journal of sports medicine and physical fitness. (1996) [Pubmed]
  5. Indinavir-related recurrent paronychia and ingrown toenails. Alam, M., Scher, R.K. Cutis; cutaneous medicine for the practitioner. (1999) [Pubmed]
  6. Lamivudine-induced paronychia. Zerboni, R., Angius, A.G., Cusini, M., Tarantini, G., Carminati, G. Lancet (1998) [Pubmed]
  7. Indinavir-induced retinoid-like effects: incidence, clinical features and management. García-Silva, J., Almagro, M., Peña-Penabad, C., Fonseca, E. Drug safety : an international journal of medical toxicology and drug experience. (2002) [Pubmed]
  8. Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab. Shu, K.Y., Kindler, H.L., Medenica, M., Lacouture, M. Br. J. Dermatol. (2006) [Pubmed]
  9. The effects of clonidine added to mepivacaine for paronychia surgery under axillary brachial plexus block. Iohom, G., Machmachi, A., Diarra, D.P., Khatouf, M., Boileau, S., Dap, F., Boini, S., Mertes, P.M., Bouaziz, H. Anesth. Analg. (2005) [Pubmed]
  10. Paronychia in association with indinavir treatment. Colson, A.E., Sax, P.E., Keller, M.J., Turk, B.K., Pettus, P.T., Platt, R., Choo, P.W. Clin. Infect. Dis. (2001) [Pubmed]
  11. Paronychia and pyogenic granuloma-like lesions with isotretinoin. Blumental, G. J. Am. Acad. Dermatol. (1984) [Pubmed]
  12. Acute paronychia after high-dose methotrexate therapy. Wantzin, G.L., Thomsen, K. Archives of dermatology. (1983) [Pubmed]
  13. Treatment of severe psoriasis with etretin (RO 10-1670). Lassus, A., Geiger, J.M., Nyblom, M., Virrankoski, T., Kaartamaa, M., Ingervo, L. Br. J. Dermatol. (1987) [Pubmed]
  14. Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor. Dainichi, T., Tanaka, M., Tsuruta, N., Furue, M., Noda, K. Dermatology (Basel) (2003) [Pubmed]
  15. Paronychia and excess granulation tissue of the toes and finger in a patient treated with indinavir. Daudén, E., Pascual-López, M., Martínez-García, C., García-Díez, A. Br. J. Dermatol. (2000) [Pubmed]
WikiGenes - Universities